Moneyta · fund managers · no sign-up needed
SILVERARC CAPITAL MANAGEMENT, LLC
FollowFiles quarterly holdings with the SEC · Q2 2026 · figures are the filer's own · filings arrive up to 45 days after quarter end
Disclosed US stock book
$962M
the filing's own total; every row accounted for
Positions
73
This quarter
+26 opened · 26 exited
Top 10 holdings
| Security | Value | Q/Q · Gold |
|---|---|---|
| ASCENDIS PHARMA A/Snew | $55M | |
| CELC | $52M | |
| COGT | $50M | |
| UROGEN PHARMA LTD | $48M | |
| IMNM | $43M | |
| DNTH | $38M | |
| RYTM | $35M | |
| ORKA | $34M | |
| GLUE | $27M | |
| SNDX | $27M |
…and 63 more positions. Quarter-over-quarter changes, adds and trims are part of the flows intelligence for Gold members.
Every position in the manager's quarterly holdings filing with the SEC is counted. A name without a link is one Moneyta does not cover yet.
Was this book followable? Gold
Every quarter since 2020, replayed at the real filing delay, against the S&P 500. The number nobody else computes.
Flows, compare, and your portfolio beside theirs Gold
Quarter-over-quarter moves, overlap with other managers, and where you stand next to them.
Further reading
Source: the manager's quarterly holdings filings with the SEC, via EDGAR. Disclosed long US positions only, not the fund's complete portfolio. Option rows show the UNDERLYING notional value the SEC requires, not premium paid: a put is bearish exposure, and notional overstates the actual bet. Educational analysis of published data. Insight, not advice.